Eloxx Pharmaceuticals, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
4.04M
on 2026-06-30, from 435K on 2025-12-31 10-Q ↗
Earlier counts are adjusted for the 1-for-11 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
1 of its filings are not read yet.
Warrants
7.43M
Warrants of every class as tagged in the XBRL facts on 2026-06-30, exercise price $0.44. 10-Q ↗
Cash
Four quarters of operating cash flow to 2026-06-30 are not all on file.
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-06-08 | Public offering incl. 3.02M pre-funded | 6,000,000 | $11.00 | $66.0M | 424B4 ↗ |
Also on file: a 1-for-11 reverse split, 2026-06-01 8-K ↗